Jonathan Bye
Lawyers
Associate in our Corporate practice, based in Northern California.
Experience
Recent Work
- Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
- CytomX Therapeutics $58.3 million at-the-market offering
- SGH $175 million convertible notes offering and capped call transactions
- IDEAYA Biosciences $302.5 million equity offering
- Recursion Pharmaceuticals $230 million follow-on offering
- Bloom Energy $402.5 million green convertible notes offering
- RxSight $115 million follow-on offering
- Nurix Therapeutics $175 million stock and pre-funded warrants offering
- Cisco Systems $13.5 billion notes offering
- IDEAYA Biosciences $350 million at-the-market offering
- IDEAYA Biosciences $143.8 million equity offering
- RAPT Therapeutics $150 million at-the-market offering
- Recursion Pharmaceuticals $300 million at-the-market offering
- IDEAYA Biosciences $250 million at-the-market offering
- IDEAYA Biosciences $201 million equity offering
- AN2 Therapeutics $100 million at-the-market offering
Education
J.D., University of Michigan Law School
- cum laude
B.A., Philosophy, UC Berkeley
Qualifications and admissions
- State of California